Genzyme and Relational Investors: Scienc...
Eades, Kenneth M.,...
Genzyme and Relational Investors: Science and Business Collide?
Eades, Kenneth M.; Matos, Pedro; Green, Rick
F-1660 | Published December 2, 2011 | 25 pages Case
Collection: Darden School of Business
Product Details
The chairman and CEO of the Genzyme Corporation, one of the country's top five biotechnology firms, has received a phone call requesting a meeting with the cofounder and principal of a large activist investment fund that now has a 2.6% stake in his company. Before meeting with him, the CEO is aware that he needs a strategy for dealing with this "activist" investor with a track record of forcing out CEOs.
0